Here we show that the same ANRIL isoforms, which were up-regulated in patients carrying the Chr9p21 atherosclerosis risk haplotype, modulate gene networks in trans leading to pro-atherogenic cellular properties. The gene discussed is CDKN2B-AS1; the disease is atherosclerosis.